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Introduction
Rap1 is signalling molecule that modulates T lympho-
cyte trafficking and activation upon antigen stimulation.
We demonstrated that transgenic mice with T cells
expressing constitutively active Rap1 (RapV12) are pro-
tected from experimental arthritis. Here, we aimed to
identify the mechanisms of protection by using a TCR
transgenic model of MOG-induced EAE (2D2 mice).
Methods
Flow cytometry and ELISA were used to analyse the
phenotype and cytokine profile of MOG-specific auto-
reactive T cells in 2D2 xRapV12, 2D2, RapV12 and wild
type (WT) mice, either in basal conditions or after in
vivo priming with MOG peptide. Clinical EAE was mon-
itored for 30 days.
Results
Under homeostatic conditions, there was a strong reduc-
tion in the number of autoreactive T cells in 2D2xRapV12
versus 2D2 animals in both the naïve and memory com-
partments, indicating that constitutive Rap1 activation
enforces central tolerance mechanisms. Analysis of the
remaining autoreactive T cells showed no differences in
T cell subsets, proliferation, apoptosis, expression of costi-
mulatory molecules and production of pro-inflammatory
cytokines. After in vivo priming with MOG, however,
we observed a profound inhibition of TNF production by
T cells expressing RapV12 whereas there was a slight
increase in IFNgamma and IL-17 production. To evaluate
the pathophysiological relevance of these alterations of
autoreactive T cells, EAE was induced in 2D2xRapV12,
2D2, RapV12 and WT littermates. In the 2D2 model,
where a significant number of autoreactive T cells are still
present despite the constitutive RapV12, we observed no
difference in EAE scores but an improved survival in the
2D2xRapV12 versus 2D2 mice (p=0.04). In WT mice, sus-
tained Rap1 activation led to increased survival (p=0.02) as
well as lower EAE scores (p=0.07).
Conclusion
Sustained activation of Rap1 reduces the autoreactive
T cell pool and affects pro-inflammatory cytokine pro-
duction by the remaining autoreactive T lymphocytes.
As in experimental arthritis, these quantitative and qua-
litative effects are associated with a protection from
autoimmune disease in EAE.
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